CLADRIBINE

Clinical Indication

Relapsing-remitting multiple sclerosis

Comments

In line with NICE TA616

Date of classification

February 2018

Review date

March 2020

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).